The targeting of BCR-ABLp210 to the bone marrow hematopoietic stem and progenitor cells, via stem cell antigen (Sca1)-BCR-ABLp210, led to a leukemia resembling human chronic phase CML [29,30]. Here, BCR is linked to leukemia.